To include your compound in the COVID-19 Resource Center, submit it here.

Sticking by Weston

Problems with delivering consistent doses will delay the launch of Weston Medical plc's Intraject pre-filled needleless drug delivery system by nine to 18 months, putting the earliest launch of an Intraject product to mid-2005. However, the company says this doesn't put its eight partnerships at risk, because

Read the full 471 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers